These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10973747)

  • 1. Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae.
    Salonen JH; Richardson MD; Gallacher K; Issakainen J; Helenius H; Lehtonen OP; Nikoskelainen J
    J Hosp Infect; 2000 Aug; 45(4):293-301. PubMed ID: 10973747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies.
    Chryssanthou E; Cherif H; Petrini B; Kalin M; Björkholm M
    Scand J Infect Dis; 2004; 36(11-12):855-9. PubMed ID: 15764173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
    Rimek D; Redetzke K; Kappe R
    Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.
    Lass-Flörl C; Gunsilius E; Gastl G; Englisch M; Koch G; Ulmer H; Dierich MP; Petzer A
    Ann Hematol; 2003 Sep; 82(9):565-9. PubMed ID: 14504812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
    Manzoni P; Arisio R; Mostert M; Leonessa M; Farina D; Latino MA; Gomirato G
    Pediatrics; 2006 Jan; 117(1):e22-32. PubMed ID: 16326690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Swinne D; Watelle M; Van der Flaes M; Nolard N
    Mycoses; 2004 Jun; 47(5-6):177-83. PubMed ID: 15189180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
    Giusiano G; Mangiaterra M; Saito VG; Rojas F; Gómez V; Díaz MC
    Mycoses; 2006 Jan; 49(1):49-54. PubMed ID: 16367819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
    Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group.
    Rotstein C; Bow EJ; Laverdiere M; Ioannou S; Carr D; Moghaddam N
    Clin Infect Dis; 1999 Feb; 28(2):331-40. PubMed ID: 10064252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole versus amphotericin B for the prevention of fungal infection in neutropenic patients with hematologic malignancy.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
    Drugs Exp Clin Res; 1999; 25(4):193-200. PubMed ID: 10442277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia.
    Dalle F; Lafon I; L'ollivier C; Ferrant E; Sicard P; Labruère C; Jebrane A; Laubriet A; Vagner O; Caillot D; Bonnin A
    Haematologica; 2008 Apr; 93(4):581-7. PubMed ID: 18322258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.